Health Care

3 Key Questions About the Obamacare Court Ruling

By Yuval Rosenberg

The fate of Obamacare may once again wind up before the Supreme Court now that a federal judge in Texas has ruled that the law is unconstitutional. U.S. District Court Judge Reed O'Connor ruled on...
Obamacare Signups Still Lagging

By The Fiscal Times Staff

Open enrollment for health insurance on the Affordable Care Act exchange (HealthCare.gov) ends in most states on Saturday, and it looks the number of signups could be significantly lower this year...
Moody’s Warns of Declining US Fiscal Strength

By The Fiscal Times Staff

Trump’s tax cuts combined with a slowing economy will diminish the United States’ “fiscal strength” over the next 10 years, Moody’s Investor Service said Wednesday. The gradual decline could pressure...
Number of Uninsured Americans Rose by 700,000 in 2017

By Yuval Rosenberg

The number of uninsured people in the United States rose by nearly 700,000 to 27.4 million in 2017, the first increase since 2010, according to an analysis by the Kaiser Family Foundation. The...
How Congress Got So Broken

By Yuval Rosenberg

More than 50 House members chose not to seek re-election in 2018, and a new report from nonprofit groups Issue One and the R Street Institute examines what drove so many to that decision. The report...

Obamacare Sign-Ups Down by 11%. Why?

By Michael Rainey

Fewer people have enrolled in health care plans through the HealthCare.gov website this year, with sign-ups down by 11 percent compared to the same period in 2017. Margot Sanger-Katz and Reed Abelson...
The 20 Most Expensive Drugs in the US

By The Fiscal Times Staff

Drug price-comparison platform GoodRx recently released an expanded rundown of the 20 most costly drugs in the U.S., based on the list price set by manufacturers — which can be very different from...
Fixing U.S. Health Care: Can States Step Up Where Washington Has Failed?

By Yuval Rosenberg

The midterm elections may have focused extensively on health care, but the results have done little to clarify where health care reform is headed. “The future of U.S. health care reform is muddier...
Narrow Networks Still Dominate Obamacare Exchanges

By Yuval Rosenberg

Networks that offer less choice of health care providers remain the most common types of plans on Affordable Care Act exchanges, with 72 percent of the market, according to a new analysis by research...
No, Ms. Ocasio-Cortez, a $21 Trillion Pentagon Accounting Error Can’t Pay for Medicare for All

By The Fiscal Times Staff

Newly elected representative and social media lightning rod Alexandria Ocasio-Cortez (D-NY) sparked a round of controversy this weekend when she compared the potential cost of Medicare for All to the...

GOP’s Latest Campaign Punch on Health Care Relies on Classic Hook: Medicare

By Julie Rovner, Kaiser Health News

Once again, Medicare is front and center in this fall’s campaigns. Democrats throughout the election season have been hammering Republicans over votes and lawsuits that would eliminate insurance...
Transfer Payments Hit $3 Trillion Annual Pace

By The Fiscal Times Staff

Total government transfers reached $3 trillion on an annualized basis for the first time in September, according to data released by the Bureau of Economic Analysis Monday. Transfer payments include...
Paid Family Leave: The Leading Democratic and Republican Proposals, Explained

By Emily Zeppieri, The Fiscal Times

Since 1993, the Family and Medical Leave Act (FMLA) has provided workers with the right to unpaid time off and guaranteed job security following qualified medical and family events, including...
Americans Are Spending More on Health Care Out of Their Own Pockets

By The Fiscal Times Staff

Americans are spending more and more on out-of-pocket health-care costs. A report released this week by the JPMorgan Chase Institute finds that annual growth in out-of-pocket spending has accelerated...
Why Trump’s Medicare Plan Won’t Cut Prices Anytime Soon

By Yuval Rosenberg

President Trump’s newly unveiled test plan to lower Medicare Part B drug costs may have limited resonance in the days before the midterm elections — and could face a difficult, if not impossible,...